BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1452215)

  • 21. HLA phenotypes and multiple basal cell carcinomas.
    Rompel R; Petres J; Kaupert K; Mueller-Eckhardt G
    Dermatology; 1994; 189(3):222-4. PubMed ID: 7949471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-ras-1 gene mutations in basal cell carcinoma: automated direct sequencing of clinical specimens.
    Wilke WW; Robinson RA; Kennard CD
    Mod Pathol; 1993 Jan; 6(1):15-9. PubMed ID: 8426854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collision tumor of cutaneous malignant melanoma and basal cell carcinoma.
    Hirakawa E; Miki H; Kobayashi S; Nomura Y; Ohmori M
    Pathol Res Pract; 1998; 194(9):649-53. PubMed ID: 9793966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
    Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
    Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
    Kohchiyama A; Oka D; Ueki H
    J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression.
    Brogelli L; Moretti S; Borgognoni L; Giannotti B
    Dermatologica; 1990; 180(2):69-72. PubMed ID: 2311798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies.
    Holden CA; Sanderson AR; MacDonald DM
    J Am Acad Dermatol; 1983 Dec; 9(6):867-71. PubMed ID: 6196384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
    Garrido F; Ruiz-Cabello F
    Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
    van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
    Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leukocyte antigen associations in basal cell carcinoma.
    Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
    J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
    Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
    Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA and skin cancer.
    Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
    An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role for Id-1 in immunobiology of normal keratinocytes and in basal cell carcinoma.
    Chaturvedi V; Bonish B; Bacon P; Qin JZ; Denning MF; Foreman K; Diaz MO; Robinson J; Nickoloff BJ
    Exp Dermatol; 2003 Jun; 12(3):255-60. PubMed ID: 12823438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HLA molecules on cells from fresh explants of human digestive tract cancer.
    Garcia-Espejo R; Alonso MC; Solana R; Pera C; Peña J
    J Immunogenet; 1986; 13(2-3):211-7. PubMed ID: 3819452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.